J. Christopher Naftzger - 10 Jul 2023 Form 3 Insider Report for Arbutus Biopharma Corp (ABUS)

Signature
/s/ David C. Hastings as attorney-in-fact for J. Christopher Naftzger
Issuer symbol
ABUS
Transactions as of
10 Jul 2023
Net transactions value
$0
Form type
3
Filing time
12 Jul 2023, 16:10:12 UTC
Previous filing
15 Aug 2022
Next filing
05 Feb 2024

No securities are beneficially owned.

Remarks:

Exhibit 24: Power of Attorney